Psych CASC / OSCE · Psychopharmacology — lithium
Explaining lithium monitoring and suicide benefit to a patient (CASC)
CASC-style communication station: shared decision on lithium vs valproate defaults, monitoring plan, interaction/sick-day rules, anti-suicide evidence, and balanced organ and pregnancy risk framing.
On this page & tools
Target exams
Station instructions (candidate)
You have 7 minutes. Explain why lithium is being offered after a manic episode and serious suicide attempt, what blood monitoring means in plain language (levels plus kidney, thyroid and calcium), how everyday medicines like ibuprofen can raise levels, and which symptoms need urgent review. Balance organ and future-pregnancy concerns against relapse prevention and anti-suicide evidence. Do not guarantee cure. Do not dismiss fears. Do not invent exact national laboratory cut-offs as universal rules — explain principles and local protocols.[1][2][3]
Marking domains
Empathy and agenda setting; accurate plain-language explanation of bipolar maintenance and why lithium is not interchangeable with "any tablet"; honest description of 12-hour level tests and organ bloods; BALANCE-informed comparison with valproate monotherapy; Cipriani anti-suicide framing without overclaim; NSAID/sick-day counselling; toxicity red flags; collaborative plan and written information.[1][2][3][5]
Model communication map
- Open: thank him; check understanding of mania recovery and suicide risk; name shared goals (stay well, stay alive, work/study).[2]
- Why lithium: strongest long-term track record for preventing mood episodes for many people; a major trial (BALANCE) found lithium-containing treatment better than valproate alone at preventing new episodes — cousin's story is not his evidence base.[1]
- Suicide context: research trials show lithium can reduce suicide deaths compared with placebo in mood disorders — part of a full safety plan, not a magic shield.[2]
- Monitoring: regular blood tests check the lithium level (usually 12 hours after the dose) and watch kidney, thyroid and calcium because lithium can affect those over time; most people manage with monitoring rather than inevitable dialysis fear.[3][5]
- Everyday risks: dehydration and anti-inflammatory painkillers can push levels up — ask before new medicines; stop and seek advice if severe vomiting/diarrhoea per sick-day plan.[5]
- Future pregnancy (if relevant): if he or a partner plans pregnancy later, we plan carefully; modern data show a modest increase in some heart problems with first-trimester exposure — specialist counselling then, not a reason to refuse life-saving treatment today without discussion.[4]
- Close: questions, written info, next blood date, crisis contacts, who to call if tremor becomes coarse, confusion, or severe unsteadiness.[5]
Common fails
- Agreeing "valproate is the same as lithium for prevention" contrary to BALANCE teaching.[1]
- Terrifying him with kidney failure without explaining monitoring and absolute-risk context.[3]
- Omitting suicide-risk rationale after a serious attempt.[2]
- Forgetting NSAID/sick-day counselling.[5]
- Guaranteeing no side effects or refusing to discuss risks.[5]
References
- [1]BALANCE investigators and collaborators, Geddes JR, Goodwin GM, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet, 2010.PMID 20092882
- [2]Cipriani A, Hawton K, Stockton S, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis BMJ, 2013.PMID 23814104
- [3]McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis Lancet, 2012.PMID 22265699
- [4]Patorno E, Huybrechts KF, Bateman BT, et al. Lithium Use in Pregnancy and the Risk of Cardiac Malformations N Engl J Med, 2017.PMID 28591541
- [5]Gitlin M Lithium side effects and toxicity: prevalence and management strategies Int J Bipolar Disord, 2016.PMID 27900734